- Home
- AMH vs ASND Comparison
AMH vs ASND Comparison
Compare AMH & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMH
- ASND
- Stock Information
- Founded
- AMH 2012
- ASND 2006
- Country
- AMH United States
- ASND Denmark
- Employees
- AMH N/A
- ASND N/A
- Industry
- AMH Real Estate Investment Trusts
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- AMH Real Estate
- ASND Health Care
- Exchange
- AMH Nasdaq
- ASND Nasdaq
- Market Cap
- AMH 12.9B
- ASND 10.6B
- IPO Year
- AMH 2013
- ASND 2015
- Fundamental
- Price
- AMH $33.33
- ASND $197.24
- Analyst Decision
- AMH Buy
- ASND Strong Buy
- Analyst Count
- AMH 13
- ASND 16
- Target Price
- AMH $40.23
- ASND $240.75
- AVG Volume (30 Days)
- AMH 2.5M
- ASND 394.0K
- Earning Date
- AMH 10-28-2025
- ASND 11-13-2025
- Dividend Yield
- AMH 3.60%
- ASND N/A
- EPS Growth
- AMH 15.35
- ASND N/A
- EPS
- AMH 1.11
- ASND N/A
- Revenue
- AMH $1,798,427,000.00
- ASND $576,332,355.00
- Revenue This Year
- AMH $8.00
- ASND $102.31
- Revenue Next Year
- AMH $4.50
- ASND $76.44
- P/E Ratio
- AMH $30.01
- ASND N/A
- Revenue Growth
- AMH 7.21
- ASND 54.50
- 52 Week Low
- AMH $31.68
- ASND $118.03
- 52 Week High
- AMH $41.41
- ASND $208.16
- Technical
- Relative Strength Index (RSI)
- AMH 35.00
- ASND 54.46
- Support Level
- AMH $34.10
- ASND $196.06
- Resistance Level
- AMH $34.85
- ASND $202.57
- Average True Range (ATR)
- AMH 0.59
- ASND 5.93
- MACD
- AMH -0.15
- ASND -1.13
- Stochastic Oscillator
- AMH 4.91
- ASND 35.62
About AMH American Homes 4 Rent of Beneficial Interest
American Homes 4 Rent is a real estate investment trust focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's geographical markets include Dallas, Texas; Indianapolis, Indiana; Atlanta, Georgia; and Charlotte, North Carolina in terms of the number of properties in each.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.